Effectiveness of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) against Invasive Pneumococcal Disease among Children under Two Years of Age in Germany-Reference-Cited by-同舟云学术

Effectiveness of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) against Invasive Pneumococcal Disease among Children under Two Years of Age in Germany

Published:2016-08-15 Issue:8 Volume:11 Page:e0161257
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

van der Linden Mark,Falkenhorst Gerhard,Perniciaro Stephanie,Fitzner Christina,Imöhl Matthias

Funder

Pfizer Pharma GmbH, Germany

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference27 articles.

1. Pneumococcal carriage in young children one year after introduction of the 13-valent conjugate vaccine in Italy;R Camilli;PLoS One,2013

2. A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting;M Hussain;Epidemiol Infect,2005

3. Empfehlungen der Ständigen Impfkommission (STIKO) am RKI (Stand Juli 2006):Begründungen zur allgemeinen Empfehlung der Impfung gegen Pneumokokken- und Meningokokken im Säuglings- und Kindesalter;Epidemiol Bull,2006

4. Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany;M van der Linden;PLoS One,2015

5. Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany;S Rückinger;Vaccine,2009

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of PCV10 and PCV13 on pneumococcal serotype 6C disease, carriage, and antimicrobial resistance;Vaccine;2024-04

2. Effectiveness of 13-valent pneumococcal conjugate vaccine on all-cause pneumonia in children under 5 years in Shanghai, China: An observational study;Vaccine;2023-09

3. Effectiveness of thirteen-valent pneumococcal conjugate vaccine to prevent serotype 3 invasive pneumococcal disease in Quebec in children, Canada;Vaccine;2023-08

4. Predicting vaccine effectiveness against invasive pneumococcal disease in children using immunogenicity data;npj Vaccines;2022-11-07

5. Cross reacting material (CRM197) as a carrier protein for carbohydrate conjugate vaccines targeted at bacterial and fungal pathogens;International Journal of Biological Macromolecules;2022-10